Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment

Clinical trial NCT05875532 · COMPLETED

Trial details

NCT number: NCT05875532
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Diseases, Interstitial

Start date: 2023-04-20
Primary completion: 2023-05-01
Enrollment: 34960

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.